Zolbetuximab for Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ILUSTRO: Phase 2 Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Clin. Cancer Res 2023 Jul 25;[EPub Ahead of Print], SJ Klempner, KW Lee, K Shitara, JP Metges, S Lonardi, DH Ilson, N Fazio, TY Kim, LY Bai, D Moran, J Yang, A Arozullah, JW Park, JJ Raizer, YJ Bang, MA ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.